ketanserin has been researched along with Thyroid Neoplasms in 1 studies
Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.
Thyroid Neoplasms: Tumors or cancer of the THYROID GLAND.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tamir, H | 1 |
| Liu, KP | 1 |
| Hsiung, SC | 1 |
| Yu, PY | 1 |
| Kirchgessner, AL | 1 |
| Gershon, MD | 1 |
1 other study available for ketanserin and Thyroid Neoplasms
| Article | Year |
|---|---|
Identification of serotonin receptors recognized by anti-idiotypic antibodies.
Topics: Androstadienes; Animals; Antibodies, Anti-Idiotypic; Antiparkinson Agents; Brain; Carrier Proteins; | 1991 |